Nimer Ortuño‐Gutiérrez

509 total citations
40 papers, 266 citations indexed

About

Nimer Ortuño‐Gutiérrez is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Nimer Ortuño‐Gutiérrez has authored 40 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Nimer Ortuño‐Gutiérrez's work include Tuberculosis Research and Epidemiology (24 papers), Leprosy Research and Treatment (17 papers) and Pneumonia and Respiratory Infections (6 papers). Nimer Ortuño‐Gutiérrez is often cited by papers focused on Tuberculosis Research and Epidemiology (24 papers), Leprosy Research and Treatment (17 papers) and Pneumonia and Respiratory Infections (6 papers). Nimer Ortuño‐Gutiérrez collaborates with scholars based in Belgium, Netherlands and Bangladesh. Nimer Ortuño‐Gutiérrez's co-authors include Bouke C. de Jong, Tom Decroo, Epco Hasker, Armand Van Deun, Alberto Piubello, Jan Hendrik Richardus, Lutgarde Lynen, Mahamadou Bassirou Souleymane, Mourad Gumusboga and Temmy Sunyoto and has published in prestigious journals such as PLoS ONE, PLoS Medicine and European Respiratory Journal.

In The Last Decade

Nimer Ortuño‐Gutiérrez

36 papers receiving 261 citations

Peers

Countries citing papers authored by Nimer Ortuño‐Gutiérrez

Since Specialization

Citations

This map shows the geographic impact of Nimer Ortuño‐Gutiérrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nimer Ortuño‐Gutiérrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nimer Ortuño‐Gutiérrez more than expected).

Fields of papers citing papers by Nimer Ortuño‐Gutiérrez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nimer Ortuño‐Gutiérrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nimer Ortuño‐Gutiérrez. The network helps show where Nimer Ortuño‐Gutiérrez may publish in the future.

Co-authorship network of co-authors of Nimer Ortuño‐Gutiérrez

This figure shows the co-authorship network connecting the top 25 collaborators of Nimer Ortuño‐Gutiérrez. A scholar is included among the top collaborators of Nimer Ortuño‐Gutiérrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nimer Ortuño‐Gutiérrez. Nimer Ortuño‐Gutiérrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pakistan on the Road to Zero Leprosy, an analysis of routine data for the period 1980–2022: a retrospective cohort study 2025 ·The Lancet Global Health ·(unknown), (unknown), Abdul Salam, (unknown), Isabel Fernandes, (unknown), Muhammad Ali, Matthew Willis, (unknown), Nimer Ortuño‐Gutiérrez, (unknown), Thomas Hambridge, (unknown), Christine Schmotzer, Epco Hasker	2
2	Roadmap towards zero leprosy, Pakistan 2025 ·Bulletin of the World Health Organization ·(unknown), (unknown), Abdul Salam, (unknown), Nimer Ortuño‐Gutiérrez, (unknown), (unknown), (unknown), Thomas Hambridge, Epco Hasker, Christine Schmotzer, Paul Saunderson	0
3	Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands 2024 ·PLoS Medicine ·Bouke C. de Jong, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Achilleas Tsoumanis, Nimer Ortuño‐Gutiérrez, Christian van der Werf, Alberto Piubello, (unknown), (unknown), Epco Hasker	2
4	Whole-genome sequencing for surveillance of antimicrobial resistance in Ecuador: present and future implications 2023 ·Revista Panamericana de Salud Pública ·William Calero‐Cáceres, Nimer Ortuño‐Gutiérrez, Temmy Sunyoto, (unknown), Carlos Bastidas‐Caldes, (unknown), Anthony Harries	6
5	Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts 2023 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), Alberto Piubello, (unknown), (unknown), (unknown), Achilleas Tsoumanis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paul L. A. M. Corstjens, Nimer Ortuño‐Gutiérrez, (unknown), Annemieke Geluk, Bouke C. de Jong, Epco Hasker	13
6	Colistin resistance in Escherichia coli and Klebsiella pneumoniae in humans and backyard animals in Ecuador 2023 ·Revista Panamericana de Salud Pública ·Carlos Bastidas‐Caldes, (unknown), Nimer Ortuño‐Gutiérrez, Temmy Sunyoto, (unknown), María Soledad Ramírez, William Calero‐Cáceres, Anthony Harries, Joaquı́n Rey, Jacobus H. de Waard, Manuel Calvopiña	14
7	Face mask sampling (FMS) for tuberculosis shows lower diagnostic sensitivity than sputum sampling in Guinea 2023 ·Annals of Clinical Microbiology and Antimicrobials ·(unknown), (unknown), Tom Decroo, (unknown), Alexandre Délamou, (unknown), Nimer Ortuño‐Gutiérrez, (unknown), Caroline Williams, (unknown), Michael R. Barer, Leen Rigouts, Bouke C. de Jong	4
8	Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study 2022 ·International Health ·Mahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, (unknown), (unknown), (unknown), Eric Adéhossi, Nimer Ortuño‐Gutiérrez, Lutgarde Lynen, Leen Rigouts, Bouke C. de Jong, Armand Van Deun, Alberto Piubello	2
9	High yield of retrospective active case finding for leprosy in Comoros 2022 ·PLoS neglected tropical diseases ·Nimer Ortuño‐Gutiérrez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bouke C. de Jong, Jan Hendrik Richardus, Epco Hasker	6
10	Less is more: Developing an approach for assessing clustering at the lower administrative boundaries that increases the yield of active screening for leprosy in Bihar, India 2022 ·PLoS neglected tropical diseases ·Nimer Ortuño‐Gutiérrez, (unknown), (unknown), (unknown), (unknown), Bouke C. de Jong, Jan Hendrik Richardus, Epco Hasker	4
11	High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal 2021 ·Public Health Action ·S Koirala, Nayab Shah, Prajjwal Pyakurel, (unknown), (unknown), (unknown), (unknown), Bhagwan Maharjan, (unknown), (unknown), Alberto Roggi, A. M. V. Kumar, Nimer Ortuño‐Gutiérrez	5
12	Low yield but high levels of multidrug resistance in urinary tract infections in a tertiary hospital, Nepal 2021 ·Public Health Action ·Ratna Baral, Lok Bahadur Shrestha, Nimer Ortuño‐Gutiérrez, (unknown), (unknown), (unknown), Sudhir Singh, (unknown), Basudha Khanal, Kalaiselvi Selvaraj, (unknown)	4
13	Exploring clustering of leprosy in the Comoros and Madagascar: A geospatial analysis 2021 ·International Journal of Infectious Diseases ·Nimer Ortuño‐Gutiérrez, (unknown), Stéphanie Ramboarina, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emmanuelle Cambau, Annemieke Geluk, Bouke C. de Jong, Jan Hendrik Richardus, Epco Hasker	13
14	Minimally invasive sampling to identify leprosy patients with a high bacterial burden in the Union of the Comoros 2021 ·PLoS neglected tropical diseases ·(unknown), Anouk van Hooij, Epco Hasker, Erik Fransén, (unknown), (unknown), (unknown), Nimer Ortuño‐Gutiérrez, (unknown), (unknown), Paul L. A. M. Corstjens, Leen Rigouts, Annemieke Geluk, Bouke C. de Jong	6
15	Mobilizing health district management teams through digital tools: Lessons from the District.Team initiative in Benin and Guinea using an action research methodology 2020 ·Learning Health Systems ·(unknown), Kéfilath Bello, (unknown), Sidikiba Sidibé, Jean‐Paul Dossou, Alexandre Délamou, (unknown), (unknown), Nimer Ortuño‐Gutiérrez, Bruno Meessen	7
16	The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance 2020 ·PLoS ONE ·Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, M. Anwar Hossain, Mourad Gumusboga, Wim Mulders, Nimer Ortuño‐Gutiérrez, Lutgarde Lynen, Bouke C. de Jong, Hans L. Rieder	13
17	High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss 2020 ·European Respiratory Journal ·Mahamadou Bassirou Souleymane, Alberto Piubello, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nimer Ortuño‐Gutiérrez, Alberto Roggi, V Schwoebel, Saïdou Mamadou, Lutgarde Lynen, Bouke C. de Jong, Armand Van Deun, Tom Decroo	12
18	Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes 2020 ·PLoS ONE ·Tom Decroo, Aung Kya Jai Maug, M. Anwar Hossain, Cécile Uwizeye, Mourad Gumusboga, (unknown), Nimer Ortuño‐Gutiérrez, Bouke C. de Jong, Armand Van Deun	6
19	Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts 2019 ·BMC Infectious Diseases ·Nimer Ortuño‐Gutiérrez, (unknown), (unknown), (unknown), (unknown), Stéphanie Ramboarina, (unknown), (unknown), (unknown), (unknown), (unknown), Jan Hendrik Richardus, Bouke C. de Jong, Epco Hasker	20
20	Offering general pediatric care during the hard times of the 2014 Ebola outbreak: looking back at how many came and how well they fared at a Médecins Sans Frontières referral hospital in rural Sierra Leone 2017 ·BMC Pediatrics ·Veerle Hermans, Rony Zachariah, Desalegn Woldeyohannes, (unknown), (unknown), Nimer Ortuño‐Gutiérrez, W. Kizito, Marcel Manzi, (unknown), Jacob Maïkéré	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact